ADBiotech Co

ADBiotech Co Operating Expenses

The Total Operating Expenses of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 6.11 B KRW. In the previous year, Total Operating Expenses was 7.76 B KRW — a change of -21.26% (lower).

Operating Expenses

6.11 BKRW

YoY

-21.26%

Last updated:

Total Operating Expenses of ADBiotech Co is 2025 6.11 B KRW. Total Operating Expenses of ADBiotech Co was 2024 7.76 B KRW. It decreases by -21.26% lower compared to the previous year.

The ADBiotech Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
3.63 B KRW
Jan 1, 2019
4.31 B KRW
Jan 1, 2020
5.31 B KRW
Jan 1, 2021
6.43 B KRW
Jan 1, 2022
7.91 B KRW
Jan 1, 2023
7.48 B KRW
Jan 1, 2024
7.76 B KRW
Jan 1, 2025
6.11 B KRW
The ADBiotech Co Operating Expenses history
YEAROperating ExpensesYoY
6.11 BKRW-21.26%
7.76 BKRW+3.75%
7.48 BKRW-5.44%
7.91 BKRW+23.18%
6.43 BKRW+20.95%
5.31 BKRW+23.19%
4.31 BKRW+18.76%
3.63 BKRW+22.40%
2.97 BKRW+22.37%
2.42 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Total Operating Expenses of ADBiotech Co is 6.11 B KRW in 2025.

Total Operating Expenses of ADBiotech Co changed from 7.76 B KRW to 6.11 B KRW, representing a -21.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ADBiotech Co

All Key Metrics — ADBiotech Co